Invasive Breast Carcinoma: Clinical Trials

104 trials for Invasive Breast Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 completed, 33 active not recruiting, 20 recruiting, 7 terminated. 41 Phase 2, 18 Not applicable, 18 Phase 1, 11 Phase 3, 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 241Active not recruiting 17, Completed 17, Recruiting 2, Terminated 2, Withdrawn 2, Suspended 1
Not applicable18Completed 7, Recruiting 7, Active not recruiting 3, Not yet recruiting 1
Phase 118Completed 8, Active not recruiting 3, Terminated 3, Recruiting 2, Withdrawn 2
Phase 311Active not recruiting 7, Suspended 2, Completed 1, Recruiting 1
Early Phase 13Completed 1, Recruiting 1, Terminated 1
Phase 41Withdrawn 1

Follow Invasive Breast Carcinoma: new trials by email Literature Review of Invasive Breast Carcinoma trials Research Report on Invasive Breast Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Biopsy Procedure, Biospecimen Collection, Echocardiography Test - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Phase 1RecruitingNational Cancer Institute (NCI)362026-10-062026-10-16
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
Abemaciclib, Biospecimen Collection, Imlunestrant - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2RecruitingJonsson Comprehensive Cancer Center422026-05-182026-08-20
Areola Preservation in NSM With Nipple Involvement
Areola-Preserving Nipple-Sparing Mastectomy with Immediate Nipple Reconstruction - Breast Cancer, Ductal Carcinoma In Situ, DCIS
Not applicableNot yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine402026-05-012026-04-22
Individual Factors Associated With Care Pathways Delays in Breast Cancer in Hauts-de-France.
Breast Cancer, Invasive Breast Carcinoma
Active not recruitingUniversity Hospital, Lille5002026-04-202026-05-12
Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer
Breast Cancer, Invasive Breast Carcinoma
Not yet recruitingAtlas University602026-04-122026-03-30
Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer
Breast Cancer, Neoadjuvant Therapy
RecruitingAtlas University802025-12-152026-03-31
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC
SLN identification using technetium-99m, SLN intra-operatory identification with radioguided surgery, Axillary Limph Node Dissection (ALND) - Invasive Breast Carcinoma, Sentinel Lymph Node Biopsy (SLNB)
Not applicableRecruitingEuropean Institute of Oncology752025-12-122026-01-06
Self-Acceptance and Supportive Accountability for Active Living Among Adults Receiving Chemotherapy
Acceptance- and Mindfulness-Based Intervention - Invasive Breast Carcinoma, Gynecologic Malignancies
Not applicableCompletedUniversity of Oklahoma422025-09-102026-10-21
Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Phase 1WithdrawnNational Cancer Institute (NCI)2025-08-042025-07-03
NearWave Optical Molecular Monitoring
NearWave monitoring - Breast Cancer, HER2-positive Breast Cancer
Not applicableRecruitingIndiana University152025-03-072026-02-17
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
Biospecimen Collection, Educational Intervention, Extended Release Metformin Hydrochloride - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3RecruitingCity of Hope Medical Center802025-01-132026-10-19
Application of Single-Port Robot-Assisted Breast-Conserving Surgery Via Axillary Approach for Breast Cancer.
robot-surgery, traditional open surgry - Invasive Breast Carcinoma
Not applicableRecruitingXu Yan642024-12-312026-08-21
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
Biopsy, Biospecimen Collection, Radiation Therapy - Breast Carcinoma, Invasive Breast Carcinoma
RecruitingM.D. Anderson Cancer Center362023-09-152026-05-06
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
Chemotherapy, Computed Tomography, Fludeoxyglucose F-18 - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 2Active not recruitingECOG-ACRIN Cancer Research Group2352023-05-102026-10-19
Metformin and Nightly Fasting in Women With Early Breast Cancer
Biospecimen Collection, Extended Release Metformin Hydrochloride, Monitoring - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2Active not recruitingM.D. Anderson Cancer Center1202023-04-042026-01-05
Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study
Intraoperative Imaging, Lumpectomy - Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma
Phase 2CompletedNorthwestern University1132022-11-282026-08-19
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
Agent Affecting Integumentary System, Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Quality-of-Life Assessment - Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma
Phase 1Active not recruitingCity of Hope Medical Center2082022-09-092026-08-17
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
Letrozole, Simvastatin - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Early Phase 1RecruitingEmory University402022-09-022026-07-17
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Questionnaire Administration, Biospecimen Collection - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
RecruitingAlliance for Clinical Trials in Oncology20002022-08-182026-10-02
Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery
Short-Term Fasting, Chemotherapy, Biospecimen Collection - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableRecruitingThomas Jefferson University552022-07-282026-09-03

Showing 20 of 104. Sign in to see all of them.

Narrower conditions

Breast Neoplasms (53)  ·  Triple Negative Breast Neoplasms (25)  ·  Carcinoma, Intraductal, Noninfiltrating (24)  ·  Breast Carcinoma In Situ (13)  ·  Carcinoma, Ductal, Breast (3)  ·  Esophageal Neoplasms (3)  ·  Inflammatory Breast Neoplasms (3)  ·  Melanoma (3)  ·  Brain Neoplasms (2)  ·  Carcinoma, Lobular (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Renal Cell (2)  ·  Colorectal Neoplasms (2)  ·  Fallopian Tube Neoplasms (2)  ·  Leukemia, Myeloid, Acute (2)

Broader conditions

Neoplasms (79)  ·  Neoplasms by Site (71)  ·  Skin Diseases (70)  ·  Skin and Connective Tissue Diseases (70)  ·  Breast Diseases (69)  ·  Neoplasms by Histologic Type (35)  ·  Neoplasms, Glandular and Epithelial (34)  ·  Carcinoma (33)  ·  Adenocarcinoma (28)  ·  Carcinoma in Situ (28)  ·  Neoplasms, Ductal, Lobular, and Medullary (26)  ·  Breast Neoplasms (16)  ·  Breast Carcinoma In Situ (15)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Head and Neck Neoplasms (4)

Interventions

Specimen Handling (17)  ·  Paclitaxel (11)  ·  Taxes (11)  ·  Carboplatin (9)  ·  Biopsy (7)  ·  Letrozole (7)  ·  Radiation (7)  ·  Radiotherapy (7)  ·  Magnetic Resonance Spectroscopy (6)  ·  Practice Guidelines as Topic (6)  ·  Standard of Care (6)  ·  Albumin-Bound Paclitaxel (5)  ·  Anastrozole (5)  ·  Cyclophosphamide (5)  ·  Doxorubicin (4)

Sponsors

M.D. Anderson Cancer Center (25)  ·  National Cancer Institute (NCI) (16)  ·  Mayo Clinic (9)  ·  Alliance for Clinical Trials in Oncology (5)  ·  ECOG-ACRIN Cancer Research Group (4)  ·  Jonsson Comprehensive Cancer Center (3)  ·  Roswell Park Cancer Institute (3)  ·  Atlas University (2)  ·  City of Hope Medical Center (2)  ·  Fred Hutchinson Cancer Center (2)  ·  Northwestern University (2)  ·  Rutgers, The State University of New Jersey (2)  ·  Thomas Jefferson University (2)  ·  University of Southern California (2)  ·  Virginia Commonwealth University (2)

Countries

United States (95)  ·  Puerto Rico (8)  ·  Canada (7)  ·  France (3)  ·  Italy (3)  ·  China (2)  ·  South Korea (2)  ·  Spain (2)  ·  Colombia (1)  ·  Germany (1)  ·  Guam (1)  ·  Ireland (1)  ·  Mexico (1)  ·  Saudi Arabia (1)  ·  South Africa (1)

Top investigators

Clinton Yam (4)  ·  Benjamin D Smith (2)  ·  William E Gillanders (2)  ·  Abenaa M Brewster (1)  ·  Alexandra Zimmer, M.D. (1)  ·  Amulya C Yellala, MD (1)  ·  Amy J Chien, MD (1)  ·  Andrew J Brenner (1)  ·  Anna Wu (1)  ·  Ayca Gucalp (1)  ·  Azadeh Nasrazad, MD,PHD (1)  ·  Azadeh Nasrazadani (1)  ·  Bhuvaneswari Ramaswamy, MD (1)  ·  Bodour Salhia, PhD (1)  ·  Bruce G Haffty (1)

Results publications

PMID 39558017, PMID 24464780, PMID 25913905, PMID 26247543, PMID 27138575, PMID 29789969, PMID 30027292, PMID 30611839, PMID 31276981, PMID 31461380, PMID 32996592, PMID 33305350, PMID 33587350, PMID 33740205, PMID 33992718, PMID 34092112, PMID 34253579, PMID 34616010, PMID 34636255, PMID 34914339, PMID 35507014, PMID 35617923, PMID 35728046, PMID 35736816, PMID 35914239, PMID 36092362, PMID 36216274, PMID 36228112, PMID 36306810, PMID 36759673, PMID 36892847, PMID 37043123, PMID 37061619, PMID 37505106, PMID 37506981, PMID 37547448, PMID 37707811, PMID 37828596, PMID 38236702, PMID 38484209, PMID 38578640, PMID 38828938, PMID 39503605, PMID 39656951, PMID 40073831, PMID 40152443, PMID 40314623, PMID 40332918, PMID 40366003, PMID 40839373

NIH funding

P30CA016672 (4), U10CA180820 (3), U10CA180821 (3), U10CA180888 (3), N01CN00034 (2), P30CA014089 (2), P30CA015083 (2), P30CA015704 (2), P30CA060553 (2), P50CA116201 (2), U10CA180868 (2), UG1CA189823 (2), UM1CA186689 (2), UM1CA186704 (2), UM1CA186712 (2)